Activation of Inflammasomes and Relevant Modulators for the Treatment of Microglia-mediated Neuroinflammation in Ischemic Stroke

Mol Neurobiol. 2024 Dec;61(12):10792-10804. doi: 10.1007/s12035-024-04225-1. Epub 2024 May 24.

Abstract

As the brain's resident immune patrol, microglia mediate endogenous immune responses to central nervous system injury in ischemic stroke, thereby eliciting either neuroprotective or neurotoxic effects. The association of microglia-mediated neuroinflammation with the progression of ischemic stroke is evident through diverse signaling pathways, notably involving inflammasomes. Within microglia, inflammasomes play a pivotal role in promoting the maturation of interleukin-1β (IL-1β) and interleukin-18 (IL-18), facilitating pyroptosis, and triggering immune infiltration, ultimately leading to neuronal cell dysfunction. Addressing the persistent and widespread inflammation holds promise as a breakthrough in enhancing the treatment of ischemic stroke.

Keywords: Inflammasome; Ischemic stroke; Microglia; Regulator.

Publication types

  • Review

MeSH terms

  • Animals
  • Humans
  • Inflammasomes* / metabolism
  • Ischemic Stroke* / drug therapy
  • Ischemic Stroke* / metabolism
  • Ischemic Stroke* / pathology
  • Microglia* / drug effects
  • Microglia* / metabolism
  • Microglia* / pathology
  • Neuroinflammatory Diseases* / drug therapy
  • Neuroinflammatory Diseases* / metabolism
  • Neuroinflammatory Diseases* / pathology

Substances

  • Inflammasomes